Apogee Therapeutics Balance Sheet (2022-2026) | APGE

Balance Sheet Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 4.97M151.89M125.10M188.27M118.32M485.46M307.30M118.78M141.79M106.92M124.19M107.91M131.55M451.80M
Short-term Investments (Quarter) 234.60M277.14M330.74M368.90M407.27M378.86M406.41M381.20M419.38M598.64M608.10M
Cash & Current Investments (Quarter) 4.97M151.89M125.10M422.87M395.46M816.20M676.20M526.05M520.65M513.33M505.39M527.29M730.19M1,059.90M
Receivables - Other (Quarter) 1.21M4.77M4.70M5.01M4.14M4.48M5.96M7.28M
Prepaid Assets (Quarter) 0.06M0.89M1.41M2.95M2.72M5.62M3.27M1.85M0.59M0.96M12.81M11.17M3.37M
Current Assets (Quarter) 152.06M130.67M426.42M398.41M820.61M681.85M534.48M529.71M521.53M516.12M540.10M741.36M1,073.80M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.38M0.70M0.71M1.42M1.96M5.70M6.44M6.03M5.69M5.28M
Long-Term Investments (Quarter) 113.39M227.75M210.42M168.11M115.80M61.60M172.73M198.35M
Long-Term Deferred Tax (Quarter) 30.75M
Other Non-Current Assets (Quarter) 0.40M0.40M0.47M0.51M0.50M7.34M8.86M8.74M8.67M8.52M
Non-Current Assets (Quarter) 3.00M3.05M118.80M241.80M224.24M192.63M141.65M86.06M195.78M219.86M
Assets (Quarter) 152.06M130.67M426.42M401.40M823.66M800.66M776.29M753.95M714.16M657.77M626.16M937.13M1,293.65M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.42M11.15M1.21M2.14M4.30M5.53M2.22M1.07M2.44M5.68M0.38M1.22M1.24M
Payables (Quarter) 0.42M11.15M1.21M2.14M4.30M5.53M2.22M1.07M2.44M5.68M0.38M1.22M1.24M
Accumulated Expenses (Quarter) 0.52M0.89M2.22M17.31M16.11M4.05M27.53M24.25M26.54M21.85M29.59M23.18M28.58M
Other Accumulated Expenses (Quarter) 0.20M1.83M0.69M1.24M2.14M1.01M1.69M
Current Leases (Quarter) 1.10M1.10M1.70M2.90M3.23M3.98M4.00M4.10M3.50M3.14M
Total Current Liabilities (Quarter) 9.98M17.61M17.18M20.56M21.55M24.62M32.61M28.56M32.96M31.55M34.05M27.91M32.95M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 3.77M8.17M28.97M28.97M148.50M148.50M
Non-Current Deferred Tax Liability (Quarter) 0.57M
Operating Leases (Quarter) 0.93M0.63M4.10M9.30M8.60M7.84M6.80M5.77M5.34M4.91M
Other Non-Current Liabilities (Quarter) 8.00M5.90M6.60M5.20M2.50M1.20M0.50M0.10M0.10M2.10M0.60M
Total Non-Current Liabilities (Quarter) 1.98M11.71M10.58M16.29M19.68M25.82M41.38M37.06M38.27M39.82M31.15M37.26M
Total Liabilities (Quarter) 4.43M24.09M9.98M46.64M17.61M17.18M21.49M22.18M27.02M41.88M37.16M40.80M38.37M39.82M33.25M37.86M
Shareholder's Equity
Common Equity (Quarter) -4.43M-24.09M-35.39M-46.64M-64.42M409.24M379.91M801.48M773.64M734.40M716.79M673.36M619.40M586.34M903.88M1,255.79M
Shareholder's Equity (Quarter) -4.43M-24.09M-35.39M-46.64M-64.42M409.24M379.91M801.48M773.64M734.40M716.79M673.36M619.40M586.34M903.88M1,255.79M
Liabilities and Shareholders Equity (Quarter) 152.06M130.67M426.42M401.40M823.66M800.66M776.29M753.95M714.16M657.77M626.16M937.13M1,293.65M
Retained Earnings (Quarter) -39.78M-71.19M-92.03M0.33M-155.86M-189.70M-238.70M0.92M1.07M-427.40M-492.40M1.08M-0.75M
Treasury Shares (Quarter) 8.02M2.66M2.32M2.09M0.13M1.61M1.42M0.25M1.03M0.20M0.64M0.36M